Loading organization details...
The organization you're looking for doesn't exist or has been removed.
Back to Organizations| Sub-Organization | Type | Status | Funding |
|---|
| Announced Date | Transaction Name | Investors | Money Raised | Lead Investors | Funding Type |
|---|
| Investor Name | Lead Investor | Funding Round | Partners |
|---|
| Organization Name | Lead Investor | Funding Round |
|---|
| Announced Date | Organization Name | Diversity Spotlight | Funding Round | Money Raised |
|---|
| Acquiree Name | Announced Date | Price | Transaction Name |
|---|
Matched by industry, location, employee size, and funding stage.
Hellerup
Survac ApS focuses on the development of peptide based therapeutic cancer vaccines. It intends to offer the vaccine candidates for licensing and collaboration agreements.
Canonical: https://fsome.com/organization/survac-420785 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.
Sign in to view detailed metrics, contact information, and financial data. Upgrade your account to access the full dataset — including funding history, team contacts, and real-time company insights.